multiple sclerosis

Teva Payout Counters Copaxone Exclusivity Loss
Bloomberg/Businessweek
Thu, 09/19/13 - 03:16 am
Teva
Copaxone
MS
multiple sclerosis
Teva Copy to Boost Billionaire-Backed Drugmaker: Corporate India
Bloomberg
Wed, 09/18/13 - 10:23 am
Copaxone
MS
multiple sclerosis
Teva
India
Natco
Sanofi wins EU approval for second MS treatment
Reuters
Tue, 09/17/13 - 09:46 am
Sanofi
Europe
MS
multiple sclerosis
Aubagio
Lemtrada
Wall Street Sees Big Biotech Making Tens of Billions in Two Critical Areas
Yahoo/Wall St 24-7
Mon, 09/16/13 - 10:09 am
biotech
Th2 immune pathway
MS
multiple sclerosis
Biogen Idec
Regeneron
Sanofi
GSK
XenoPort to continue development of XP23829 after Phase 1 results
Yahoo/Fly on the Wall
Mon, 09/9/13 - 05:18 pm
XenoPort
XP23829
psoriasis
multiple sclerosis
Biogen may be capturing 50% of new MS patients, says Cowen
Yahoo/Fly on the Wall
Fri, 09/6/13 - 08:58 am
MS
Biogen Idec
multiple sclerosis
Tecfidera
European Commission Approves Genzyme’s Once-Daily, Oral Multiple Sclerosis Treatment Aubagio (teriflunomide)
Yahoo/BusinessWire
Sat, 08/31/13 - 11:13 am
Genzyme
multiple sclerosis
Aubagio
MS
Novartis' MS drug Gilenya tied to rare brain infection
Fierce Pharma
Fri, 08/30/13 - 09:32 am
Novartis
Gilenya
MS
multiple sclerosis
PML
FDA
Biogen Multiple Sclerosis Drug May Become Blockbuster
investors.com
Sat, 08/24/13 - 11:38 am
Biogen Idec
MS
multiple sclerosis
Tecfidera
Multiple Sclerosis market to reach more than $18bn by 2018
Datamonitor Healthcare
Tue, 08/20/13 - 12:13 pm
MS
multiple sclerosis
Biogen Idec
Tecfidera
Receptos Could Meet With A More Positive Reception
Seeking Alpha
Wed, 08/14/13 - 10:16 am
Receptos
Novartis
Gilenya
MS
multiple sclerosis
RPC1063
Biogen Gains A Leg Up In Fiercely Competitive MS Field
Seeking Alpha
Thu, 08/8/13 - 06:54 pm
BiogenIdec
MS
multiple sclerosis
Tecfidera
This Company Is Tackling Multiple Sclerosis Head On
Motley Fool
Sat, 08/3/13 - 10:15 am
MS
multiple sclerosis
Genzyme
Lemtrada
Sanofi
Patient taking Novartis MS pill developed rare disease
Reuters
Tue, 07/30/13 - 01:20 pm
Novartis
MS
multiple sclerosis
Gilenya
Can Biogen Keep The Party Going After A Flawless Drug Launch? Comment Now Follow Comments
Forbes
Thu, 07/25/13 - 09:49 am
drug launches
Biogen Idec
Tecfidera
MS
multiple sclerosis
A Look at Four Major Players in Multiple Sclerosis Treatments
Motley Fool
Wed, 07/24/13 - 12:55 pm
MS
multiple sclerosis
XenoPort
BiogenIdec
Novartis
Alkermes
Tecfidera
Gilenya
ALKS 7106
Biogen shares slip on MS patient death, company says no connection
Marketwatch
Wed, 07/24/13 - 09:56 am
Biogen Idec
MS
multiple sclerosis
Tecfidera
Medical Pot: A Drugmaker Bets on Marijuana to Treat Diabetes, Epilepsy, and More
Bloomberg/Businessweek
Fri, 07/19/13 - 12:05 pm
marijuana
GW Pharma
diabetes
epilepsy
Sativex
multiple sclerosis
Alkermes Adds Multiple Sclerosis Pill To Expanding Pipeline
TheStreet.com
Thu, 07/18/13 - 09:55 am
Alkermes
multiple sclerosis
MS
monomethyl fumarate
Tecfidera
BiogenIdec
Feds Probe Novartis Over Marketing Of Its Gilenya MS Pill
Pharmalot
Thu, 07/18/13 - 09:33 am
Novartis
MS
multiple sclerosis
Gilenya

Pages